PALM BEACH, Florida, May 2, 2017 /PRNewswire/ --
As the cannabinoid-basedproducts and treatment market continues to rapidly expand, cannabis and legal marijuana innovators are pouring more funds into CBD-based research and product development. The current cannabinoid market continues to present revenue boosting opportunities,
Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, medical devices and its subsidiary Cannabis Therapeutics Inc. are proud to announce the achievements and updates on its CBD-based nutraceutical patent compound.
Dr. Aube, Earth Science Tech's CEO and CSO, meets with Dr. Domenico and his chemical engineer every Tuesday, at Smart Medicines and have been working on three formulas. The formulas are in a solid, liquid, and semi solid form. Out of all three forms ETST's science team sees the semi solid formula's potential as a huge success. The final product looks similar to regular mustard, but it's a very special condiment that keeps all properties of full spectrum hemp oil. To read this and more news for Earth Science Tech, go to: http://marketnewsupdates.com/news/etst.html
Both the color and taste of the formula can be changed with ETST's U.S. Provisional Application N. 62/061,577, filed October 8, 2014 and ETST's U.S. Provisional Application No. 62/102,538, filed January 12, 2015 along with other food coloring and natural flavors. It's formulated with high industrial hemp CBD oil (30%) and CBD concentration, and can be packaged in a tube to be consumed directly as it is (half a tea spoon 3 times/day) as a nutraceutical product.
The product can keep the same texture and inert ingredients as the nutraceutical product but, with modulations of the amount of hemp oil (between 5% and 30%), and can be sold as a functional food, a condiment to flavor everyday food, as well as a dietary supplement.
Nickolas S. Tabraue ETST's President and COO updates the market, "We are still on track to release our highly anticipated, world-first High Grade Hemp CBD Strawberry Orange Blossom, Pet CBD, and our new edible line in mid-May as mentioned on April 20, 2017. Bottling and packaging look to commence during the first week of May and we plan on showing images on our new products and packaging very soon. Our Chief Sales Officer, Gabriel Aviles, has been receiving endless pre-order requests on our new line and we are on pace to have a record breaking month. Aside from our new products, packaging, and positive revenue forecast, we are looking to finalize a few major breakthroughs I will be excited to share when we have something more concrete in place. We greatly appreciate our loyal stakeholders' support and look forward on showing the public where all the support has taken us, and what it has helped us build."
In other Industry news and developments:
Cannabis Sativa, Inc. (OTCQB: CBDS) closed up over 15% on Monday at $5.8908 by the market close. Cannabis Sativa. Inc. announced in late April that the Company has developed a "hi" branded infused honey product (hi honey) which is made from rich African honey and infused with CBD or THC. CBDS President David Tobias said that, "the hi honey flavor is rich, dark and unique." Mr. Tobias went on to express his belief that, "superfood honey contains powerful compounds including probiotics and polyphenols, which could help fight inflammation and protect cells from damage."
Vitality Biopharma, Inc. (OTCQB: VBIO) closed up also on Monday at $2.35 by the market close. Vitality Biopharma, a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, on 4/20 announced the release of one of the first clinical reports detailing the ability of cannabinoid therapy to induce remission in a pediatric inflammatory bowel disease patient.
Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, late last week announced that its Chairman and Chief Executive Officer, Derek Peterson, will present at the 2017 Canaccord Genuity Cannabis Conference on Wednesday, May 10th at 1:00 PM Eastern at The Intercontinental Barclay New York in New York City. Derek Peterson, Chairman and CEO of Terra Tech Corp., commented, "Canaccord is one of the leading investment banks with expertise in the cannabis sector and we are pleased to be invited to present at its conference. Terra Tech continues to go from strength to strength and we look forward to educating interested investors about our business."
mCig, Inc. (OTCQB: MCIG) a leading distributor of innovative products, technologies and services for the global medical cannabis industry is pleased to announce yesterday the launch of 420 Cloud on Google Play (and available soon in the Apple store), the company's latest addition to its technology division. 420 Cloud is an app-based unified community platform, sort of, 'LinkedIn meets Tinder of cannabis', and intuitively connects like-minded individuals whether they are patients, doctors, growers, dispensaries, investors, businesses, entrepreneurs, or recreational users through targeted filters, interests, jobs, news and more. mCig will promote its app through various channels totaling a reach of over one billion.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Earth Science Tech, Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Contact Information: Media Contact email: [email protected] +1-(561)-325-8757
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All